Strategic partnerships Compass Pathways is actively engaging with prestigious research institutions and government entities (e.g., Kings College London, U.S. Department of Veterans Affairs) to run trials and expand access, presenting opportunities to collaborate on multicenter studies, data sharing arrangements, and joint development programs.

Clinical trial expansion Strong emphasis on COMP360 for treatment-resistant depression and PTSD with ongoing Phase 3 progress suggests opportunities to offer regulatory, clinical trial operations, patient recruitment, and CRO/CTO support services to accelerate timelines and broaden trial sites.

Regulatory and export enablement UK-US manufacturing and regulatory pathways are being prepared (UK contract manufacturing for export to the US); potential sales opportunities include GMP manufacturing, supply chain consulting, and pharmacovigilance services to support global commercialization.

Strategic funding and governance Significant capital backing and board expansion imply ongoing corporate development activity, creating openings for advisory, investor relations tooling, data analytics platforms for clinical and financial metrics, and strategic planning services.

Technology-enabled ops Adoption of SAS, Tableau, Airflow, Terraform, MongoDB and other enterprise tools indicates a maturation of data and operations; opportunities exist to offer analytics, data integration, cloud infrastructure optimization, and security/compliance solutions tailored to biotech R&D workflows.